Related Experiment Video
Updated: Mar 28, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine
Stefania Bulotta1, Marilena Celano1, Giuseppe Costante1,2
1Department of Health Sciences, University "Magna Graecia" of Catanzaro, Campus "S. Venuta", 88100, Catanzaro, Italy.
Abstract:
Efficient treatment of radio refractory thyroid cancer is still a major challenge. The recent identification of genetic and epigenetic alterations present in almost all differentiated tumors has revealed novel molecular targets, which can hopefully be exploited to create new treatments for these tumors. This review looks briefly at some of the innovative strategies currently being investigated for the treatment the radioiodine-resistant thyroid cancers.
Insights
Treating radioiodine-refractory thyroid cancer remains difficult. New molecular targets identified in differentiated thyroid tumors offer hope for developing innovative therapies against radioiodine-resistant thyroid cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Radioiodine-refractory thyroid cancer presents significant therapeutic challenges.
- Differentiated thyroid tumors exhibit numerous genetic and epigenetic alterations.
- These alterations represent potential targets for novel treatment strategies.
Purpose of the Study:
- To review innovative treatment strategies for radioiodine-resistant thyroid cancers.
- To highlight the potential of molecular targets in overcoming treatment resistance.
Main Methods:
- Literature review of current research on thyroid cancer treatment.
- Analysis of genetic and epigenetic alterations in differentiated thyroid tumors.
- Exploration of emerging therapeutic approaches.
Main Results:
- Identification of novel molecular targets in radioiodine-resistant thyroid cancer.
- Overview of innovative strategies under investigation.
- Potential for improved treatment outcomes.
Conclusions:
- Targeting specific molecular alterations offers a promising avenue for treating radioiodine-resistant thyroid cancer.
- Continued research into these novel strategies is crucial for advancing patient care.
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy

